# The National Health Service (Prescribing and Charging Amendments Relating to Pandemic Influenza) Regulations 2009, Regulation 2: Amendment of the National Health Service (Charges for Drugs and Appliances) Regulations 2000


In the National Health Service (Charges for Drugs and Appliances) Regulations 2000, after regulation 7B, insert the following regulation—
“Exemption from charges in respect of listed medicines
7C. (1) No patient shall be liable to pay a charge under these Regulations in respect of the following medicines—
(a) oseltamivir (marketed as Tamiflu);
(b) zanamivir (marketed as Relenza),
in the circumstances set out in paragraph (2).
(2) Those circumstances are that—
(a) the Secretary of State has made arrangements for supplying the medicine to patients free of charge; or
(b) the NHS body that is responsible for the arrangements under which the medicine is supplied has made arrangements, with the approval of the Secretary of State, for supplying the medicine to patients free of charge,
and the patient is supplied with the medicine under those arrangements.”.

---
Source: https://www.legislation.gov.uk/uksi/2009/2230/regulation/2 (the official version)
Page: https://openlegislation.uk/national-health-service-prescribing-and-charging-amendments-relating-to-pandemic-influenza-regulations-2009/regulation-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

